Study of a combination of fenugreek/phaseolamin as a new weight loss agent

Phase 2

Completed

• Conditions: Obesity; Diet and Nutrition - Obesity

• Registration Number: ACTRN12607000130460
• Lead Sponsor: Southern European Health Marketing Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-02-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 39

Inclusion Criteria

Overweight as defined by body mass index 30-40kg/m2Generally healthyWeight stable over previous 3 monthsWilling and able to give written informed consent.

Exclusion Criteria

Diabetic (receiving pharmacological treatments for diabetes)Pregnant, breastfeeding, or intending to become pregnant during the studyAny medications, or medical conditions that might, in the opinion of the Principal Investigator, affect participant safety or outcomeCurrently on an alternative weight loss programme or planning to start a programme during the study durationHas a pace-makerPlanning international travel during the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Weight loss[At 12 weeks]

Secondary Outcome Measures

Name	Time	Method
Weight loss[At 4 and 8 weeks];Blood hormal changes and HbA1C changes [At 12 weeks];Tolerability data [At 4, 8 and 12 weeks]